SCHEMBL5283839

SCHEMBL5283839

CC(C)=N/N=c1\sc2ccccc2n1C(C)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.43
SMN1; SMN2 Q16637 6/20 0.43
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
HTT P42858 3/20 0.43
KMT2A Q03164 5/20 0.40
MEN1 O00255 3/20 0.40
LMNA P02545 3/20 0.40
GAA P10253 3/20 0.38
HIF1A Q16665 1/20 0.36
GLA P06280 1/20 0.36
ALDH1A1 P00352 5/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
F12 P00748 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5283708 0.87 MAPT (0.42) MAPTSMN1; SMN2NPC1RAB9AHTT
SCHEMBL4615946 0.80 ALDH1A1 (0.50) MAPTSMN1; SMN2NPC1RAB9AHTT
SCHEMBL29774515 0.78 MAPT (0.64) MAPTSMN1; SMN2NPC1RAB9AHTT
SCHEMBL5278390 0.78 MAPT (0.64) MAPTSMN1; SMN2NPC1RAB9AHTT
SCHEMBL5278396 0.78 MAPT (0.64) MAPTSMN1; SMN2NPC1RAB9AHTT
SCHEMBL5282522 0.75 NPSR1 (0.55) MAPTSMN1; SMN2NPC1RAB9AHTT
SCHEMBL5282524 0.75 NPSR1 (0.55) MAPTSMN1; SMN2NPC1RAB9AHTT
SCHEMBL5281931 0.75 KMT2A (0.47) MAPTSMN1; SMN2NPC1RAB9AHTT
SCHEMBL5281927 0.75 KMT2A (0.47) MAPTSMN1; SMN2NPC1RAB9AHTT
SCHEMBL5283238 0.73 MAPT (0.43) MAPTSMN1; SMN2NPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599178-B1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AG (DE) 2007-12-19 EP disclosed
US-7294151-B2 Means and method for dyeing keratin fibres WELLA AG (DE) 2007-11-13 US disclosed
US-20060070190-A1 Means and method for dyeing keratin fibres KOYO SEIKO CO., LTD. (JP) 2006-04-06 US disclosed
EP-1599178-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES Wella Aktiengesellschaft (DE) 2005-11-30 EP disclosed
WO-2004078151-A1 MEANS AND METHOD FOR DYEING KERATIN FIBRES WELLA AKTIENGESELLSCHAFT (DE) 2004-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060070190-A1 Means and method for dyeing keratin fibres KRT18, KLK5, KIT MAPT 1807/4885SMN1; SMN2 3523/4885NPC1 4843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.